scout
Commentary|Videos|March 27, 2025

Dr Morgans on Standardizing the Management of Bone/Cardiac Health With Systemic Therapy in Prostate Cancer

Fact checked by: Chris Ryan

Alicia Morgans, MD, MPH, discusses the importance of managing bone and cardiac health in patients with prostate cancer receiving systemic therapy.

Alicia Morgans, MD, MPH, a physician and medical director of the Survivorship Program at Dana-Farber Cancer Institute; and an associate professor of medicine at Harvard Medical School, underscored the need to standardize the management of bone, cardiac, and other complications in patients undergoing systemic therapy for prostate cancer.

Morgans led a session on the management of the complications of systemic therapy at the 2025 Bridging the Gaps in Prostate Cancer meeting.

Newsletter

Stay up to date on the most recent and practice-changing oncology data


Latest CME